Literature DB >> 9704641

Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis.

R Brouwer1, W Vree Egberts, P H Jongen, B G van Engelen, W J van Venrooij.   

Abstract

OBJECTIVE: To investigate the incidence of autoantibodies directed to deproteinized transfer RNA(His) (tRNA(His)) in anti-Jo-1 positive myositis patients and to determine the major B cell epitope.
METHODS: One hundred sixty-seven myositis sera were screened by immunoblotting and enzyme-linked immunosorbent assay for the presence of anti-Jo-1 antibody. Autoantibodies directed to deproteinized RNA were detected by immunoprecipitation. Ribonuclease cleavage experiments were performed to determine the tRNA(His)-specific features important for recognition.
RESULTS: Approximately one-third of the anti-Jo-1 positive sera also contained autoantibodies recognizing tRNA(His). This recognition was independent of modified bases, but the presence of stabilizing Mg2+ ions appeared to be essential for efficient immunoprecipitation. Transfer RNA(His)-specific features in the anticodon loop were not protected from ribonuclease cleavage by bound antibodies, while protection of bases located in the D and T loops was observed.
CONCLUSION: A significant number of anti-Jo-1 positive myositis sera contain anti-tRNA(His) activity. Formation of the major autoepitope on tRNA(His) is strongly dependent on proper folding of this molecule mediated by an interaction between D and T loops which is stabilized by either modified residues or Mg2+ ions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704641     DOI: 10.1002/1529-0131(199808)41:8<1428::AID-ART12>3.0.CO;2-J

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Autoantibody profiles in the sera of European patients with myositis.

Authors:  R Brouwer; G J Hengstman; W Vree Egberts; H Ehrfeld; B Bozic; A Ghirardello; G Grøndal; M Hietarinta; D Isenberg; J R Kalden; I Lundberg; H Moutsopoulos; P Roux-Lombard; J Vencovsky; A Wikman; H P Seelig; B G van Engelen ; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

Review 2.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

3.  High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders.

Authors:  G J D Hengstman; L van Brenk; W T M Vree Egberts; E L van der Kooi; G F Borm; G W A M Padberg; W J van Venrooij; B G M van Engelen
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Inosine and N1-methylinosine within a synthetic oligomer mimicking the anticodon loop of human tRNA(Ala) are major epitopes for anti-PL-12 myositis autoantibodies.

Authors:  H F Becker; Y Corda; M B Mathews; J L Fourrey; H Grosjean
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

5.  Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.

Authors:  Puja Srivastava; Sanjay Dwivedi; Ramnath Misra
Journal:  Rheumatol Int       Date:  2016-05-14       Impact factor: 2.631

Review 6.  Idiopathic inflammatory myopathy: autoantibody update.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

7.  Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.

Authors:  Rick Brouwer; Wilma T M Vree Egberts; Gerald J D Hengstman; Reinout Raijmakers; Baziel G M van Engelen; Hans Peter Seelig; Manfred Renz; Rudolf Mierau; Ekkehard Genth; Ger J M Pruijn; Walther J van Venrooij
Journal:  Arthritis Res       Date:  2001-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.